Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis

Area of Science:

• Allergology and Immunology
• Otorhinolaryngology

Background:

• Allergic rhinitis is a prevalent condition impacting quality of life.
• The incidence of allergic rhinitis has been increasing globally.
• Effective management strategies for allergic rhinitis are crucial.

Purpose of the Study:

• To evaluate the efficacy of subcutaneous injectable immunotherapy for allergic rhinitis.
• To assess the impact of immunotherapy on key symptoms: nasal itching, sneezing, rhinorrhea, and nasal congestion.

Main Methods:

• Retrospective analysis of 281 patient records.
• Allergen identification via skin prick tests (acari, fungi, pet hair, pollen, feathers).
• Treatment involved subcutaneous specific immunotherapy with environmental hygiene measures.

Main Results:

• A significant reduction in symptom severity scores was observed.
• Average symptom score decreased from 2.08 pre-treatment to 0.44 post-treatment.
• This represents an approximate 79% overall improvement in allergic rhinitis symptomatology.

Conclusions:

• Subcutaneous immunotherapy effectively reduces symptoms of allergic rhinitis.
• The treatment enhances the quality of life for patients with allergic rhinitis.
• Subcutaneous immunotherapy is a valuable therapeutic option for allergic rhinitis.